Multiple Sclerosis Long Term Effectiveness of Alemtuzumab

被引：0
|
作者：
Ameri, Abdol A.
机构：
来源：
AKTUELLE NEUROLOGIE | 2016年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [1] Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
    Hill-Cawthorne, Grant A.
    Button, Tom
    Tuohy, Orla
    Jones, Joanne L.
    May, Karen
    Somerfield, Jennifer
    Green, Alison
    Giovannoni, Gavin
    Compston, D. Alastair S.
    Fahey, Michael T.
    Coles, Alasdair J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (03): : 298 - 304
  • [2] Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
    Tuohy, Orla
    Costelloe, Lisa
    Hill-Cawthorne, Grant
    Bjornson, Ingunn
    Harding, Katharine
    Robertson, Neil
    May, Karen
    Button, Tom
    Azzopardi, Laura
    Kousin-Ezewu, Onajite
    Fahey, Michael T.
    Jones, Joanne
    Compston, D. Alastair S.
    Coles, Alasdair
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (02): : 208 - 215
  • [3] Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study
    Moser, Tobias
    Foettinger, Fabian
    Hitzl, Wolfgang
    Novotna, Bianka
    Berger, Thomas
    Bsteh, Gabriel
    Di Pauli, Franziska
    Hegen, Harald
    Kornek, Barbara
    Langenscheidt, Dieter
    Sellner, Johann
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (06): : 1442 - 1455
  • [4] Alemtuzumab in multiple sclerosis: long-term follow-up of the early cohorts
    Brown, J. W. L.
    Tuohy, O.
    Kousin-Ezewu, O.
    Azzopardi, L.
    Button, T.
    Mccarthy, C.
    Alli, T.
    Callan, C.
    Folks, M.
    Heller, S.
    Laidley, H.
    Nourallah, B.
    O'Neill, C.
    Obute, D.
    Piper, R.
    Smith, O. Prankerd
    Wickham, H.
    Zheng, X.
    May, K.
    Gerritz, A.
    Compston, D. A. S.
    Jones, J. L.
    Coles, A. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 790 - 791
  • [5] Alemtuzumab for multiple sclerosis
    不详
    [J]. LANCET, 2012, 380 (9856): : 1792 - 1792
  • [6] Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort
    Willis, M. D.
    Harding, K. E.
    Pickersgill, T. P.
    Wardle, M.
    Pearson, O. R.
    Scolding, N. J.
    Smee, J.
    Robertson, N. P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (09) : 1215 - 1223
  • [7] Alemtuzumab for multiple sclerosis
    Riera, Rachel
    Porfirio, Gustavo J. M.
    Torloni, Maria R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [8] Alemtuzumab for Multiple Sclerosis
    Mark D. Willis
    Neil P. Robertson
    [J]. Current Neurology and Neuroscience Reports, 2016, 16
  • [9] Alemtuzumab in Multiple Sclerosis
    Azzopardi, Laura
    Coles, Alasdair
    [J]. NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 79 - 82
  • [10] Alemtuzumab for multiple sclerosis
    Riera, Rachel
    Torloni, Maria Regina
    Martimbianco, Ana Luiza C.
    Pacheco, Rafael L.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
12345